LifeStance Health Group Inc LFST.OQ reported a quarterly adjusted loss of 1 cent per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -6 cents. The mean expectation of eight analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results to range from -4 cents to -1 cents per share.
Revenue rose 10.6% to $345.31 million from a year ago; analysts expected $345.22 million.
LifeStance Health Group Inc's reported EPS for the quarter was a loss of 1 cent.
The company reported a quarterly loss of $3.79 million.
LifeStance Health Group Inc shares had fallen by 24.6% this quarter and lost 47.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 8.7% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for LifeStance Health Group Inc is $8.25, about 52.7% above its last closing price of $3.90
This summary was machine generated from LSEG data August 7 at 04:45 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -0.03 | -0.01 | Beat |
Mar. 31 2025 | -0.03 | 0.00 | Beat |
Dec. 31 2024 | -0.03 | -0.02 | Beat |
Sep. 30 2024 | -0.07 | -0.02 | Beat |